Shenzhen Salubris Pharmaceuticals (002294.SZ): Enalapril (enalapril maleate tablets) receives new indications in drug registration certificate.

date
05/09/2025
avatar
GMT Eight
Shineway Technologies (002294.SZ) announced that the company has received approval from the National Medical Products Administration for the issuance of Enda Duotze tablets...
Shenzhen Salubris Pharmaceuticals (002294.SZ) announced that the company has received the approved and issued drug registration certificate for the drug Enarodustat Tablets (Enarol) from the National Medical Products Administration. The drug is approved for the treatment of anemia in chronic kidney disease (CKD) patients undergoing dialysis (including hemodialysis and peritoneal dialysis).